Assignee
GLORIANA THERAPEUTICS SARL
6 granted patents·3 pending applications·3 citations·filing 2015–2021
Top patents by PatentIndex Score
9 records- 0179US10047150B2Anti-neublastin antibodies and uses thereofGLORIANA THERAPEUTICS SARL·Filed 2015·Granted Aug 14, 2018·3 cites·9 claims
- 0274US12396957B2Cell lines and their use in encapsulated cell biodeliveryGLORIANA THERAPEUTICS SARL·Filed 2021·Granted Aug 26, 2025·0 cites·11 claims
- 0367US10888526B2Cell lines and their use in encapsulated cell biodeliveryGLORIANA THERAPEUTICS SARL·Filed 2017·Granted Jan 12, 2021·0 cites·24 claims
- 0461US9884023B2Cell lines and their use in encapsulated cell biodeliveryGLORIANA THERAPEUTICS SARL·Filed 2015·Granted Feb 6, 2018·0 cites·17 claims
- 0552US10835664B2Implantable cell device with supportive and radial diffusive scaffoldingGLORIANA THERAPEUTICS SARL·Filed 2017·Granted Nov 17, 2020·0 cites·16 claims
- 0649US2021069407A1Implantable cell device with supportive and radial diffusive scaffoldingGLORIANA THERAPEUTICS SARL·Filed 2020·Application pending·0 cites
- 0745US2022048984A1Mammalian Cell Culture-Produced Neublastin AntibodiesGLORIANA THERAPEUTICS SARL·Filed 2019·Application pending·0 cites
- 0841US10717965B2Mammalian cell culture-produced neublastin antibodiesGLORIANA THERAPEUTICS SARL·Filed 2018·Granted Jul 21, 2020·0 cites·17 claims
- 0923US2018264081A1Therapeutic protein formulationsGLORIANA THERAPEUTICS SARL·Filed 2016·Application pending·0 cites
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →